XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Dec. 29, 2023
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
Three Months EndedThree Months Ended
December 29, 2023December 30, 2022
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$152.6 $141.3 $89.4 $81.5 
Restricted cash1.4 1.4 1.2 1.3 
Total as presented in the Condensed Consolidated Statements of Cash Flows$154.0 $142.7 $90.6 $82.8 
Schedule of Restrictions on Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
Three Months EndedThree Months Ended
December 29, 2023December 30, 2022
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$152.6 $141.3 $89.4 $81.5 
Restricted cash1.4 1.4 1.2 1.3 
Total as presented in the Condensed Consolidated Statements of Cash Flows$154.0 $142.7 $90.6 $82.8 
Schedule of Customers with a Significant Portion of Revenue During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:
Three Months Ended
December 29, 2023December 30, 2022
Canon Medical Systems Corporation14.7 %20.1 %
Schedule of Product Warranty Liability The following table reflects the changes in the Company’s accrued product warranty:
Three Months Ended
(In millions)December 29, 2023December 30, 2022
Accrued product warranty, at beginning of period$7.7 $7.9 
New accruals charged to cost of revenues3.7 2.8 
Product warranty expenditures(3.4)(3.0)
Accrued product warranty, at end of period$8.0 $7.7